CD36 and diabetic cardiomyopathy: In a work presented by Lujin Wu et al., it was demonstrated that the PPARα-CD36 pathway was found to be a major modulator of cardiac fatty acid metabolism, influencing fatty acid uptake and oxidation in a diabetic cardiomyopathy mouse model.